Skye Bioscience, Inc. Proceeds from Issuance of Debt
Skye Bioscience, Inc. (SKYE) reported Proceeds from Issuance of Debt of $9.30 thousand for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2019-05-10
- Skye Bioscience, Inc. proceeds from issuance of debt for the quarter ending 2019-03-31 was $9.30K.
- Skye Bioscience, Inc. proceeds from issuance of debt for the quarter ending 2013-07-31 was $0.00.
| Period end | Proceeds from Issuance of Debt 3 month | Proceeds from Issuance of Debt 6 month | Proceeds from Issuance of Debt 9 month |
|---|---|---|---|
| 2019-03-31 | $9.30K 10-Q · filed 2019-05-10 | ||
| 2014-07-31 | $50.00K 10-Q · filed 2014-09-15 | ||
| 2013-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | $32.00K 10-Q · filed 2014-09-15 | |
| 2013-04-30 | $32.00K 10-Q · filed 2014-06-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |